Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
PIK3C3
REST API REST API
Homo sapiens
PIK3C3 is differentially expressed in 314 experiments: 133 organism parts: liver, bone marrow, ... (131 more);, 165 disease states: normal, glioblastoma, ... (163 more);, 87 cell types 430 cell lines 40 compound treatments and 81 other conditions.
Synonyms Vps34
Orthologs VPS34 (Saccharomyces cerevisiae)   pik3c3 (Danio rerio)   ENSCING00000003389 (Ciona intestinalis)   PIK3C3 (Gallus gallus)   Pik3c3 (Rattus norvegicus)   Pik3c3 (Mus musculus)   PIK3C3 (Bos taurus)   Pi3K59F (Drosophila melanogaster)   pik3c3 (Xenopus laevis)   Q6JDI4_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, protein binding, phosphotransferase activity, alcohol group as acceptor, autophagic vacuole assembly, inositol or phosphatidylinositol kinase activity, innate immune response, 1-phosphatidylinositol-3-kinase activity, insulin receptor signaling pathway, fibroblast growth factor receptor signaling pathway, ATP binding, endosome organization, cell cycle, midbody, cytokinesis, regulation of protein secretion, nucleotide binding, binding, protein kinase activity, response to leucine, protein phosphorylation, phosphatidylinositol-mediated signaling, phosphatidylinositol phosphorylation, phosphatidylinositol 3-kinase complex, phosphatidylinositol 3-kinase activity
InterPro Term PI3K_C2, PInositide-3_kin_accessory_dom, PI3K_Vps34, PI3/4_kinase_cat
UniProt Accession A8MYT4, Q8NEB9
Search EB-eye ENSG00000078142
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-22541, E-GEOD-6573, E-GEOD-3526, E-MTAB-62, ... (26 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-19639, ... (41 experiments)

Factor Value U/D Experiments
MCF-7
3
E-GEOD-20081, E-GEOD-19639, E-GEOD-3529
SW480
3
E-MTAB-37, E-GEOD-18005, E-MEXP-1014
SNU16
2
E-MTAB-37, E-GEOD-15460
U87
2
E-GEOD-20089, E-MEXP-903
A549
2
E-GEOD-6013, E-GEOD-3202
CaHPV10
1
E-MTAB-37
424 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-22373, E-GEOD-21668, E-GEOD-3920, E-MEXP-750, ... (43 experiments)

Factor Value U/D Experiments
endothelial cell
3
E-GEOD-19240, E-GEOD-3920, E-GEOD-3998
memory B cell
2
E-MEXP-2360, E-TABM-702
adipocyte
2
E-AFMX-5, E-TABM-145
mesenchymal stem cell
2
E-GEOD-9894, E-GEOD-2248
testis - leydig cell
1
E-AFMX-5
CD3- CD56bright CD62L+ NK cell
1
E-GEOD-21774
81 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-2466, E-MEXP-1121, E-GEOD-16363, E-MTAB-62, ... (65 experiments)

Factor Value U/D Experiments
glioblastoma
1
3
E-GEOD-4290, E-GEOD-6014, E-GEOD-4412, E-MTAB-62
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
prostate carcinoma
2
E-MTAB-37, E-MEXP-2034
Burkitt's lymphoma
2
E-MTAB-37, E-GEOD-96
Emery-Dreifuss muscular dystrophy
2
E-GEOD-3307, E-MTAB-62
colon carcinoma
2
E-MTAB-37, E-MTAB-62
159 more value(s).


Compound treatment

studied in E-GEOD-1417, E-GEOD-5824, E-MEXP-1958, E-MEXP-1269, E-GEOD-3284, ... (26 experiments)

Factor Value U/D Experiments
ethanol
2
E-GEOD-3113, E-MEXP-2241
phenol
1
E-GEOD-6907
potassium dichromate
1
E-GEOD-6907
CNOT7+CNOT8
1
1
E-MEXP-2218
sevoflurane
1
E-GEOD-4386
ponasterone A
1
E-GEOD-3113
34 more value(s).


A rna yield

studied in E-TABM-325

Factor Value U/D Experiments
137.36
1
1
E-TABM-325


Age at onset
studied in E-GEOD-21521

Agent
studied in E-GEOD-19519

Biopsy tissue
studied in E-GEOD-5851

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-860, E-MEXP-1251, ... (9 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-MEXP-2359, E-GEOD-2666, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22541, E-TABM-147, E-GEOD-21138, ... (6 experiments)

Environmental stress
studied in E-GEOD-1643

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-3494, E-GEOD-6532

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (9 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-GEOD-2466, E-GEOD-22593, E-GEOD-18005, ... (14 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-7011, E-MEXP-2657, E-TABM-127, E-GEOD-20504, ... (11 experiments)

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276, E-GEOD-2748

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-5764, E-MEXP-2069, E-GEOD-1926, ... (36 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254, E-GEOD-980, E-GEOD-17400, E-GEOD-6802 ... (5 experiments)

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Light
studied in E-GEOD-1725

Localisation of metastases
studied in E-GEOD-22541

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-AFMX-1, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-1309, E-GEOD-22309, E-GEOD-21750, E-GEOD-1657, E-GEOD-1460, ... (6 experiments)

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Pr ihc
studied in E-GEOD-21653

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-10896

RNAi
studied in E-MEXP-2115, E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-GEOD-3697, ... (7 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sample status
studied in E-GEOD-30573

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-MEXP-70, E-GEOD-18995

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643, E-GEOD-2466, E-GEOD-7307, E-GEOD-16363

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-4883, E-GEOD-20114, E-GEOD-11886, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Test result
studied in E-TABM-276, E-GEOD-2748

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-12198 ... (5 experiments)

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-89, E-GEOD-4290, E-GEOD-22541, E-GEOD-4922

Tumor size
studied in E-GEOD-6532

Processing time: 0.404 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM